dc.creator | Marican, Adolfo | |
dc.creator | Avila-Salas, Fabian | |
dc.creator | Valdés, Oscar | |
dc.creator | Wehinger, Sergio | |
dc.creator | Villaseñor, Jorge | |
dc.creator | Fuentealba, Natalia | |
dc.creator | Arenas-Salinas, Mauricio | |
dc.creator | Argandoña, Yerko | |
dc.creator | Carrasco-Sánchez, Verónica | |
dc.creator | Durán-Lara, Esteban F. | |
dc.date | 2022-12-29T17:43:39Z | |
dc.date | 2022-12-29T17:43:39Z | |
dc.date | 2018 | |
dc.date.accessioned | 2024-05-02T20:30:11Z | |
dc.date.available | 2024-05-02T20:30:11Z | |
dc.identifier | http://repositorio.ucm.cl/handle/ucm/4284 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/9274532 | |
dc.description | This study describes the in-silico rational design, synthesis and evaluation of cross-linked polyvinyl alcohol hydrogels containing γ-cyclodextrin (γ-CDHSAs) as platforms for the sustained release of prednisone (PDN). Through in-silico studies using semi-empirical quantum mechanical calculations, the effectiveness of 20 dicarboxylic acids to generate a specific cross-linked hydrogel capable of supporting different amounts of γ-cyclodextrin (γ-CD) was evaluated. According to the interaction energies calculated with the in-silico studies, the hydrogel made from PVA cross-linked with succinic acids (SA) was shown to be the best candidate for containing γ-CD. Later, molecular dynamics simulation studies were performed in order to evaluate the intermolecular interactions between PDN and three cross-linked hydrogel formulations with different proportions of γ-CD (2.44%, 4.76% and 9.1%). These three cross-linked hydrogels were synthesized and characterized. The loading and the subsequent release of PDN from the hydrogels were investigated. The in-silico and experimental results showed that the interaction between PDN and γ-CDHSA was mainly produced with the γ-CDs linked to the hydrogels. Thus, the unique structures and properties of γ-CDHSA demonstrated an interesting multiphasic profile that could be utilized as a promising drug carrier for controlled, sustained and localized release of PDN. | |
dc.language | en | |
dc.rights | Atribución-NoComercial-SinDerivadas 3.0 Chile | |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | |
dc.source | Pharmaceutics, 10(1), 30 | |
dc.subject | Drug delivery | |
dc.subject | Crosslinking | |
dc.subject | Prednisone | |
dc.subject | Cyclodextrins | |
dc.subject | Swelling | |
dc.subject | Accumulative release | |
dc.subject | Thermogravimetric analysis | |
dc.title | Rational design, synthesis and evaluation of γ-CD-containing cross-linked polyvinyl alcohol hydrogel as a prednisone delivery platform | |
dc.type | Article | |